Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Joey Azofeifa"'
Autor:
Maureen Caligiuri, Grace L. Williams, Jennifer Castro, Linda Battalagine, Erik Wilker, Lili Yao, Shawn Schiller, Angela Toms, Ping Li, Eneida Pardo, Bradford Graves, Joey Azofeifa, Agustin Chicas, Torsten Herbertz, Maria Lai, Joel Basken, Kenneth W. Wood, Qunli Xu, Sylvie M. Guichard
Publikováno v:
Targeted Oncology. 18:269-285
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b83a4b5ffa700d6591f630c62f30ad00
https://doi.org/10.1007/s11523-023-00949-7
https://doi.org/10.1007/s11523-023-00949-7
Autor:
Timothy Read, Zoe Winigrad, Ardeshir Goliaei, Cole Liechty, Carter Grochala, Leah Damon, John Dickson, Jason Harris, Casey Pham, Jenna Rimel, Christy Rhine, Dave Simpson, Eric Martin, Joey Azofeifa
Publikováno v:
Cancer Research. 83:2755-2755
Induction of Ferroptosis is a promising strategy for treating therapy-resistant tumors including mesenchymal tumor types. We performed a phenotypic screen to identify small molecules that induce ferroptosis in mesenchymal cancer cells by screening fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a857376544104ddfc028527cdc3b23a0
https://doi.org/10.1158/1538-7445.am2023-2755
https://doi.org/10.1158/1538-7445.am2023-2755
Autor:
Timothy Read, David Simpson, Jenna Rimel, Christy Rhine, Casey Pham, Cole Liechty, Eric Martin, Joey Azofeifa
Publikováno v:
Cancer Research. 83:4913-4913
Inhibition of the GPX4 enzyme leads to the rapid accumulation of toxic lipid peroxides and cell death through a process known as ferroptosis. This mechanism has recently garnered significant attention in the field of oncology because many difficult-t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed8d3218918e67fb7ed11bfa4f5bfb49
https://doi.org/10.1158/1538-7445.am2023-4913
https://doi.org/10.1158/1538-7445.am2023-4913
Autor:
Alison D. Parisian, Caitlin Miller, Fabian Ortega, Leslie Hodges-Gallagher, Susanna Barratt, Joey Azofeifa, Peter J. Kushner, David Kulp, Cyrus L. Harmon
Publikováno v:
Cancer Research. 82:5375-5375
OP-1250 is an orally-bioavailable complete estrogen receptor antagonist (CERAN) previously shown to shrink wild-type and Y537S mutant estrogen receptor-positive (ER+) tumors in multiple preclinical xenograft models. To better understand the effects o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e81f95f3ec55a06070792087b6e716a7
https://doi.org/10.1158/1538-7445.am2022-5375
https://doi.org/10.1158/1538-7445.am2022-5375